Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
SDA1 domain-containing protein 1 (SDAD1) is a human protein required for the export of 60S pre-ribosomal subunits from the nucleus to the cytoplasm[7][5][4]. It is involved in ribosomal large subunit biogenesis and nucleocytoplasmic transport of these subunits[4][7]. While SDAD1 does not fit classic therapeutic target classes such as receptors or enzymes, its expression has been implicated in colon cancer cell proliferation, migration, and invasion, making it of interest in oncology research[6]. No drugs are currently known to directly target SDAD1, and it is not typically used as a biomarker or known to present specific therapeutic safety concerns.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on SDA1 domain-containing protein 1 (SDAD1).